Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia

1. Martín-Sánchez, E.
2. Blanco, L.
3. Kim, P.S.
4. Bisht, K.
5. Wang, H.
6. Van de Velde, H.
7. Jelinek, T.
8. Simoes, C.
9. Prosper, F.
10. San Miguel, J.F.
11. Alfonso, A.
12. Bergua, J.
13. Rodríguez-Veiga, R.
14. Vives, S.
15. Martínez-Cuadrón, D.
16. Montesinos, P.
17. Paiva, B.
18. Zabaleta, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1182/BLOODADVANCES.2024013212 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus